
Record Year for AACR Annual Meeting 2024: Summary of Cutting-Edge Science and More!
A recap of the plenary sessions, cutting-edge science, clinical trials, and more covered by the AACR blog.
A recap of the plenary sessions, cutting-edge science, clinical trials, and more covered by the AACR blog.
The AACR Annual Meeting 2024 Opening Ceremony showcased impactful initiatives impacting cancer research.
A few important details to help attendees get the most out of their experience at the AACR Annual Meeting...
Experience the annual undergraduate poster competition at the AACR Annual Meeting through photos.
International award and grant recipients from the Annual Meeting 2024 talk about defeating cancer globally.
Patient advocates at the AACR Annual meeting 2024 brought their perspectives to cancer researchers.
The closing plenary of the AACR Annual Meeting 2024 recapped basic science, prevention, clinical advances, and more.
Researchers around the world are designing and implementing methods to increase access to cancer care in low-resource areas.
The latest installment of this quarterly series highlights innovative research approaches reported at the AACR Annual Meeting 2024.
What did we learn about cancer in 2024? How did research advance our understanding of cancer? What new approvals...
For the past five years, cohorts of talented young researchers from around the world have participated in the AACR...
The AACR-Women in Cancer Research constituency group celebrates its 25th anniversary this year.
Event cochair Dr. Michael Caligiuri shares how attendees can form connections to take science from bench to market.
The 2024 AACR June L. Biedler Prize for Cancer Journalism winners were honored during the AACR Annual Meeting 2024.
A session at the AACR Annual Meeting 2024 offered advice on better ways to communicate science to the public....
The CheckPoints is a band comprised of cancer researchers, medical oncologists, and other professionals in the field of immuno-oncology.
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
Experts discussed "Discovery Science in Early Cancer Biology and Interception" at a plenary during the AACR Annual Meeting 2024.
NCI Director Kimryn Rathmell evoked Taylor Swift to present her vision of the 360 era for cancer research.
Four of the 2023 GSITA recipients explain how the program has benefited their careers.
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
A plenary session at the AACR Annual Meeting 2024 explored how metastases adapt to—and help shape—their new environments.
The AACR Annual Meeting 2024 Opening Plenary showed how researchers are inspiring science, fueling progress, and revolutionizing care.
At the AACR Annual Meeting 2024, researchers discussed innovative approaches to decipher the complexities of tumor ecosystems.
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.